Dino Moretti1, Martin Gonzalo Buncuga2, Carlos Mariano Scolari Pasinato3, Francisco Esteban Rossi4, Nadia Daniela Quiñones5, Carlos Dario Laudanno6. 1. Medico. morettidino@hotmail.com. 2. Medico. Servicio de Clínica Médica, Sanatorio Delta. martinbuncuga@hotmail.com. 3. Medico. Servicio de Clínica Médica, Sanatorio Delta. carlosscolari@yahoo.com.ar. 4. Medico. Servicio de Clínica Médica, Sanatorio Delta. panchorocanrol@hotmail.com. 5. Medica. Servicio de Clínica Médica, Sanatorio Delta. coti_q@hotmail.com. 6. Medico. Servicio de Clínica Médica, Sanatorio Delta. carloslaudanno@hotmail.com.
Abstract
Introduction: To study in Pluripathological patients (PP) if the PROFUND index, an objective multidimensional prognostic score, is superior to the intuition of the clinician to predict death during the first year of follow-up after hospitalization in a general ward. Methods: Prospective and observational study. Adult pluripathological patients were included. Variables: PROFUND index, subjective prognosis of death (PSM). Do you think this patient will die in the next 12 months?: “yes” PSM (+) “no” PSM (-). Mortality 12 months after discharge. Results: 92 patients were analyzed. The average age was 75.3 (± 9.5) years and 51.1% male. 47 patients (51.6%) died. The average PROFUND index was 6.9 (± 4.5) points and the PS was (+) at 46.7%. Within follow-up, 65.9% (29 of 44) and 38.3% (18 of 47) of patients with a PROFUND index> 6 and ≤6 points, respectively, died (p = 0.0021). Of the 43 patients with PS (+) 58.1% died and of the 48 with PS (-) 45.8% (p = 0.1003). From the Cox model, the risk of dying is 2 times higher in patients with a PROFUND index> 6 points (HR: 2,269 95% CI: 1,231-4,184). The AUC to predict 12-month mortality from the PROFUND index and PS were: 0.712 (95% CI: 0.607-0.817) and 0.561 (95% CI: 0.458-0.664) respectively (p 0.0212). Conclusion: In hospitalized patients with pluripathology, the PROFUND index exceeds the 12-month mortality prognostic capacity of the treating clinician. Universidad Nacional de Córdoba.
Introduction: To study in Pluripathological patients (PP) if the PROFUND index, an objective multidimensional prognostic score, is superior to the intuition of the clinician to predict death during the first year of follow-up after hospitalization in a general ward. Methods: Prospective and observational study. Adult pluripathological patients were included. Variables: PROFUND index, subjective prognosis of death (PSM). Do you think this patient will die in the next 12 months?: “yes” PSM (+) “no” PSM (-). Mortality 12 months after discharge. Results: 92 patients were analyzed. The average age was 75.3 (± 9.5) years and 51.1% male. 47 patients (51.6%) died. The average PROFUND index was 6.9 (± 4.5) points and the PS was (+) at 46.7%. Within follow-up, 65.9% (29 of 44) and 38.3% (18 of 47) of patients with a PROFUND index> 6 and ≤6 points, respectively, died (p = 0.0021). Of the 43 patients with PS (+) 58.1% died and of the 48 with PS (-) 45.8% (p = 0.1003). From the Cox model, the risk of dying is 2 times higher in patients with a PROFUND index> 6 points (HR: 2,269 95% CI: 1,231-4,184). The AUC to predict 12-month mortality from the PROFUND index and PS were: 0.712 (95% CI: 0.607-0.817) and 0.561 (95% CI: 0.458-0.664) respectively (p 0.0212). Conclusion: In hospitalized patients with pluripathology, the PROFUND index exceeds the 12-month mortality prognostic capacity of the treating clinician. Universidad Nacional de Córdoba.
Authors: Xavier Gómez-Batiste; Marisa Martínez-Muñoz; Carles Blay; Jose Espinosa; Joan C Contel; Albert Ledesma Journal: Curr Opin Support Palliat Care Date: 2012-09 Impact factor: 2.302
Authors: Geoffrey K Mitchell; Hugh E Senior; Joel J Rhee; Robert S Ware; Sharleen Young; Patrick Ck Teo; Scott Murray; Kirsty Boyd; Josephine M Clayton Journal: Palliat Med Date: 2017-04-28 Impact factor: 4.762
Authors: J Amblàs-Novellas; S A Murray; J Espaulella; J C Martori; R Oller; M Martinez-Muñoz; N Molist; C Blay; X Gómez-Batiste Journal: BMJ Open Date: 2016-09-19 Impact factor: 2.692